ArticleEJHaem2024

Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirine.

Mehdi Hamadani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.